<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04531982</url>
  </required_header>
  <id_info>
    <org_study_id>ACP-103-064</org_study_id>
    <nct_id>NCT04531982</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia</brief_title>
  <acronym>ADVANCE-2</acronym>
  <official_title>A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ACADIA Pharmaceuticals Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ACADIA Pharmaceuticals Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive&#xD;
      placebo in the treatment of negative symptoms of schizophrenia&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 5, 2020</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Negative Symptom Assessment-16 (NSA-16) total score - change from Baseline to Week 26</measure>
    <time_frame>26 Weeks Treatment Duration</time_frame>
    <description>The NSA-16 is a 16-item scale that can be completed in approximately 15 to 20 minutes. The NSA-16 has been validated for the assessment of the negative symptoms of schizophrenia and assesses 5 domains of negative symptoms: (1) communication, (2) emotion/affect, (3) social involvement, (4) motivation, and (5) retardation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression of Schizophrenia Scale-Severity (CGI-SCH-S) of negative symptoms score - change from Baseline to Week 26</measure>
    <time_frame>26 Weeks Treatment Duration</time_frame>
    <description>The CGI-SCH-S is a clinician-rated, 7-point scale that is designed to evaluate positive, negative, depressive, cognitive symptoms, and overall severity in schizophrenia. For the purposes of this study, only the negative symptoms will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression of Schizophrenia Scale-Improvement (CGI-SCH-I) of negative symptoms score at Week 26</measure>
    <time_frame>26 Weeks Treatment Duration</time_frame>
    <description>The CGI-SCH-I is a clinician-rated, 7-point scale that is designed to evaluate change in positive, negative, depressive, cognitive symptoms, and overall severity in schizophrenia. For the purposes of this study, only the negative symptoms will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of CGI-SCH-I of negative symptoms responders (CGI-SCH-I of negative symptoms score of 1 or 2) at Week 26</measure>
    <time_frame>26 Weeks Treatment Duration</time_frame>
    <description>The CGI-SCH-I is a clinician-rated, 7-point scale that is designed to evaluate change in positive, negative, depressive, cognitive symptoms, and overall severity in schizophrenia. For the purposes of this study, only the negative symptoms will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Personal and Social Performance (PSP) scale score - change from Baseline to Week 26</measure>
    <time_frame>26 Weeks Treatment Duration</time_frame>
    <description>The PSP is a validated, 100-point, single-item rating scale to assess the psychosocial functioning of subjects with schizophrenia. Ratings are based on the assessment of subject functioning across four domains of socially useful activities (e.g., work and study, personal and social relationships, self-care, and disturbing and aggressive behavior).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of NSA-16 responders (≥20%and ≥30% reduction in NSA-16 total score) at Week 26</measure>
    <time_frame>26 Weeks Treatment Duration</time_frame>
    <description>The NSA-16 is a 16-item scale that can be completed in approximately 15 to 20 minutes. The NSA-16 has been validated for the assessment of the negative symptoms of schizophrenia and assesses 5 domains of negative symptoms: (1) communication, (2) emotion/affect, (3) social involvement, (4) motivation, and (5) retardation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive and Negative Syndrome Scale (PANSS) total score - change from Baseline to Week 26</measure>
    <time_frame>26 Weeks Treatment Duration</time_frame>
    <description>The PANSS is a 30-item scale used to evaluate the presence, absence, and severity of schizophrenia symptoms. The 30 items are arranged as 7 positive symptom items, 7 negative symptom items, and 16 general psychopathology symptom items. The PANSS total score can range from a minimum of 30 to a maximum of 210.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PANSS negative subscores - change from Baseline to Week 26</measure>
    <time_frame>26 Weeks Treatment Duration</time_frame>
    <description>The PANSS is a 30-item scale used to evaluate the presence, absence, and severity of schizophrenia symptoms. The 30 items are arranged as 7 positive symptom items, 7 negative symptom items, and 16 general psychopathology symptom items. The PANSS total score can range from a minimum of 30 to a maximum of 210.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PANSS Marder factor (negative symptoms) score - change from Baseline to Week 26</measure>
    <time_frame>26 Weeks Treatment Duration</time_frame>
    <description>The PANSS is a 30-item scale used to evaluate the presence, absence, and severity of schizophrenia symptoms. The 30 items are arranged as 7 positive symptom items, 7 negative symptom items, and 16 general psychopathology symptom items. The PANSS total score can range from a minimum of 30 to a maximum of 210.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">426</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Drug - Pimavanserin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pimavanserin 34 mg taken as two tablets + background antipsychotic, once daily by mouth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo + background antipsychotic, taken as two tablets, once daily by mouth</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pimavanserin</intervention_name>
    <description>Pimavanserin 34 mg, taken as two blinded 17 mg tablets once daily by mouth</description>
    <arm_group_label>Drug - Pimavanserin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo, taken as two blinded tablets once daily by mouth</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female, ≥18 and ≤55 years of age at the time of Screening&#xD;
&#xD;
          -  Has a caregiver or some other identified responsible person (e.g., family member,&#xD;
             social worker, caseworker, or nurse) considered reliable by the Investigator in&#xD;
             providing support to the subject to help ensure compliance with study treatment, study&#xD;
             visits, and protocol procedures, and who is also able to provide input helpful for&#xD;
             completing study rating scales&#xD;
&#xD;
          -  Diagnosis of schizophrenia made ≥1 year prior to Screening&#xD;
&#xD;
          -  Is being treated must be one of the antipsychotics listed below:&#xD;
&#xD;
               -  Aripiprazole&#xD;
&#xD;
                    -  Aripiprazole long-acting injectables&#xD;
&#xD;
                    -  Abilify Maintena®&#xD;
&#xD;
               -  Aristada®&#xD;
&#xD;
               -  Asenapine&#xD;
&#xD;
               -  Brexpiprazole&#xD;
&#xD;
               -  Cariprazine&#xD;
&#xD;
               -  Lurasidone&#xD;
&#xD;
               -  Olanzapine&#xD;
&#xD;
               -  Paliperidone extended release (ER) (≤9 mg)&#xD;
&#xD;
               -  Paliperidone palmitate&#xD;
&#xD;
                    -  Invega Sustenna® (≤156 mg)&#xD;
&#xD;
                    -  Invega Trinza® (≤546 mg)&#xD;
&#xD;
                    -  Trevicta® (≤350 mg)&#xD;
&#xD;
                    -  Xeplion® (≤100 mg)&#xD;
&#xD;
               -  Risperidone&#xD;
&#xD;
               -  Risperidone long-acting injection&#xD;
&#xD;
          -  Must be medically stable and has been medically stable for at least 12 weeks prior to&#xD;
             Screening, in the opinion of the Investigator&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Has a current comorbid psychiatric disorder other than schizophrenia or a disorder&#xD;
             that would interfere with the ability to complete study assessments&#xD;
&#xD;
          -  Is at a significant risk of suicide, in the opinion of the Investigator&#xD;
&#xD;
          -  Has a significant risk of violent behavior in the opinion of the Investigator&#xD;
&#xD;
          -  A urine drug screen (UDS) result at Baseline that indicates the presence of any tested&#xD;
             prohibited substance of potential abuse, including marijuana&#xD;
&#xD;
          -  Is taking a medication or drug or other substance that is prohibited according to this&#xD;
             protocol, including medications that prolong the QT interval, strong cytochrome P450&#xD;
             (CYP) 3A4 enzyme (CYP3A4) inhibitors and inducers&#xD;
&#xD;
          -  Known family or personal history or symptoms of long QT syndrome or risk factors for&#xD;
             torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia&#xD;
             or hypomagnesemia, and the presence of congenital prolongation of the QT interval&#xD;
&#xD;
          -  Current evidence, or history within the previous 12 weeks prior to Screening, of a&#xD;
             serious and/or unstable psychiatric, neurologic, cardiovascular, respiratory,&#xD;
             gastrointestinal, renal, hepatic, hematologic, or other medical disorder, including&#xD;
             cancer or malignancies that in the judgment of the Investigator would jeopardize the&#xD;
             safe participation of the subject in the study&#xD;
&#xD;
          -  Has moderate to severe congestive heart failure&#xD;
&#xD;
          -  Has a history of myocardial infarction within 6 months prior to enrollment&#xD;
&#xD;
          -  Has a body mass index (BMI) &lt;19 or ≥35 at Screening&#xD;
&#xD;
        Additional inclusion/exclusion criteria apply. Patients will be evaluated at screening to&#xD;
        ensure that all criteria for study participation are met. Patients may be excluded from the&#xD;
        study based on these assessments (and specifically, if it is determined that their baseline&#xD;
        health and condition do not meet all prespecified entry criteria).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sandra Filosi</last_name>
    <phone>6092506920</phone>
    <email>sfilosi@acadia-pharm.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>CENydET- Centro Neurobiologico y de Estres Traumatico-Biopsychomedical Research Group SRL</name>
      <address>
        <city>Ciudad Autonoma Buenos Aires</city>
        <zip>1058 AAJ</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>FunDamoS</name>
      <address>
        <city>Ciudad Autonoma Buenos Aires</city>
        <zip>C1405BOA</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fundación para el Estudio y Tratamiento de las Enfermedades Mentales - FETEM</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aires</city>
        <zip>C1133AAH</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Resolution Psicopharmacology Research Institute</name>
      <address>
        <city>Ciudad de Mendoza</city>
        <zip>5502</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MHAT &quot;Dr. Hristo Stambolski&quot;, EOOD</name>
      <address>
        <city>Kazanlak</city>
        <state>Stara Zagora</state>
        <zip>6100</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mental Health Center Prof. Dr. Ivan Temkov - Burgas EO Burgas; Department for Treatment of Emergency Psychiatric Conditions</name>
      <address>
        <city>Burgas</city>
        <zip>8000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Psychiatric Hospital - Kardzhali, EOOD</name>
      <address>
        <city>Kardzhali</city>
        <zip>6600</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Psychiatric Hospital - Lovech</name>
      <address>
        <city>Lovech</city>
        <zip>5500</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>UMHAT 'Dr. Georgi Stranski', EAD</name>
      <address>
        <city>Pleven</city>
        <zip>5800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center Mentalcare OOD</name>
      <address>
        <city>Plovdiv</city>
        <zip>4004</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MC-Hipokrat-N E00D</name>
      <address>
        <city>Plovdiv</city>
        <zip>4028</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Medical Centre &quot;Sveti Naum&quot;</name>
      <address>
        <city>Sofia</city>
        <zip>1113</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>DCC &quot;Sv. Vrach and Sv. Sv. Kuzma and Damyan&quot;, OOD</name>
      <address>
        <city>Sofia</city>
        <zip>1408</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;UMHAT Alexandrovska EAD, Sofia; Clinic of Psychiatry, First Department of Psychiatry &quot;</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center Hera EOOD</name>
      <address>
        <city>Sofia</city>
        <zip>1510</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center Intermedica, OOD</name>
      <address>
        <city>Sofia</city>
        <zip>1680</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>DCC &quot;Mladost M&quot; - Varna, OOD</name>
      <address>
        <city>Varna</city>
        <zip>9020</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mental Health Center - Veliko Tarnovo EOOD,</name>
      <address>
        <city>Veliko Tarnovo</city>
        <zip>5000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mental Health Center - Vratsa EOOD, Vratsa; Department of Psychiatry</name>
      <address>
        <city>Vratsa</city>
        <zip>3000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic for psychiatry Vrapce 536</name>
      <address>
        <city>Zagreb</city>
        <zip>10090</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic for psychiatry Vrapce 537</name>
      <address>
        <city>Zagreb</city>
        <zip>10090</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic for psychiatry Vrapce 550</name>
      <address>
        <city>Zagreb</city>
        <zip>10090</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic for psychiatry Vrapce 557</name>
      <address>
        <city>Zagreb</city>
        <zip>10090</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>NeuropsychiatrieHK s.r.o.</name>
      <address>
        <city>Hradec Králové</city>
        <zip>503 41</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Narodni ustav dusevniho zdravi</name>
      <address>
        <city>Klecany</city>
        <zip>25067</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>A-SHINE s.r.o.</name>
      <address>
        <city>Plzen</city>
        <zip>31200</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CLINTRIAL s.r.o.</name>
      <address>
        <city>Praha 10</city>
        <zip>100 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>MUDr. Tibor Miklos</name>
      <address>
        <city>Praha 10</city>
        <zip>106 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mathe es Tarsa Bt.</name>
      <address>
        <city>Kalocsa</city>
        <state>Bacs</state>
        <zip>6300</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Semmelweis University Department of Psychiatry and Psychotherapy</name>
      <address>
        <city>Budapest</city>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nyiro Gyula Korhaz - Orszagos Pszichiatriai es Addiktologiai Intezet</name>
      <address>
        <city>Budapest</city>
        <zip>1135</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>PsychoTech Kft.</name>
      <address>
        <city>Pecs</city>
        <zip>7633</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico U.O.C. Psichiatria - Padiglione Alfieri, primo piano&quot;</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele (San Raffaele Turro)</name>
      <address>
        <city>Milano</city>
        <zip>20127</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Neuromeda, JSC</name>
      <address>
        <city>Kaunas</city>
        <zip>50185</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Romuvos klinika, UAB</name>
      <address>
        <city>Kaunas</city>
        <zip>LT-44279</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kaunas City Outpatient Clinic, Public Institution</name>
      <address>
        <city>Kaunas</city>
        <zip>LT-48259</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Silutes Mental Health and Psychotherapy Center, JSC</name>
      <address>
        <city>Silute</city>
        <zip>99142</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Podlaskie Centrum Psychogeriatrii</name>
      <address>
        <city>Bialystok</city>
        <zip>15-756</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Przychodnia Srodmiescie Sp. z o. o.</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-080</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Badan Klinicznych P.I. House Sp. z o.o.</name>
      <address>
        <city>Gdańsk</city>
        <zip>80-546</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Care Clinic centrum Medyczne</name>
      <address>
        <city>Katowice</city>
        <zip>40-568</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Specjalistyczna Praktyka Lekarska Marek Domański</name>
      <address>
        <city>Lublin</city>
        <zip>20-582</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MSCZ im. prof. J. Mazurkiewicza</name>
      <address>
        <city>Pruszków</city>
        <zip>05-802</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ośr. Badań Klin. CLINSANTE S.C.</name>
      <address>
        <city>Torun</city>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>State budget healthcare Institution of Stavropol region &quot;Regional specialized psychiatric hospital #2&quot;.</name>
      <address>
        <city>Tonnel'nyy</city>
        <state>Stavropol Region</state>
        <zip>357034</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>GUZ Lipetsk Regional psychoneurological Hospital #1</name>
      <address>
        <city>Lipetsk</city>
        <zip>398007</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>&quot;SBIH of Moscow &quot;&quot;Psychiatric Clinical Hospital # 4 n.a. P.B. Gannushkin&quot;&quot; Short name: PCH N4 n.a. P.B.Gannushkin&quot;</name>
      <address>
        <city>Moscow</city>
        <zip>107076</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>SBIH of Moscow &quot;Psych Clinical Hospital #1 N.A. Alekseev&quot;</name>
      <address>
        <city>Moscow</city>
        <zip>117152</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saint-Petersburg state healthcare institution &quot;Saint Nicolas wonderworker psychiatric hospital&quot;</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>190121</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;FSBI &quot;National medical scientific center of psychiatry and neurology n.a. V.M. Bekhterev&quot; MoH Short name: NMSC of Psy&amp;Neuro n.a. Bekhterev, 12 dep.&quot;</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>192019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Saint-Petersburg Scientific Research Psychoneurological Institute n.a. V.M. Bekhterev&quot;</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>192019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>V. M. Bekhterev National Research Medical Center For Psychiatry and Neurology</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>192019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saint Petersburg State Budget Healthcare Institution &quot;City Psychiatric Hospital No. 6 (Inpatient Department with Treatment Center)</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>193167</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saint Petersburg State Public Institution of Healthcare &quot;City Psychiatric Hospital #3 n.a. I. I. Skvortsov-Stepanov&quot;,</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Petersburg SHI &quot;Psychoneurological Dispensary #10&quot;</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>190121</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Saint-Petersburg Scientific Research Psychoneurological Institute n.a. V.M. Bekhterev&quot;.</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>192019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>SPHI &quot;City Mental Hospital #3 n.a. I.I.Skvortsov-Stepanov&quot;</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Budget Healthcare Institution &quot;Samara Psychiatric Hospital</name>
      <address>
        <city>Samara</city>
        <zip>443016</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>FSBEI HE &quot;Smolensk State Medical University&quot; of the MoH of the RF (Clinical Research Centre of diagnostics and medicines)</name>
      <address>
        <city>Smolensk</city>
        <zip>214019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinika StoLet&quot; Ltd.</name>
      <address>
        <city>Tomsk</city>
        <zip>634009</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Budget healthcare Institution of Yaroslavl region &quot;Yaroslavl region clinical psychiatric hospital&quot;</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150003</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital Center &quot;Dr. Dragisa Misovic-Dedinje&quot;, Clinic of Psychiatry</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institute of Mental health</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Center Kragujevac, Clinic of Psychiatry</name>
      <address>
        <city>Kragujevac</city>
        <zip>34000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Psychiatric Clinic, Clinical Center Kragujevac</name>
      <address>
        <city>Kragujevac</city>
        <zip>34000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Center Nis, Mental Health Protection Clinic</name>
      <address>
        <city>Nis</city>
        <zip>18000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>8035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hospital Gregorio Marañon</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CSM La Corredoria</name>
      <address>
        <city>Oviedo</city>
        <zip>33011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro de Salud Parquesol, 2ª planta - Servicio de Psiquiatria</name>
      <address>
        <city>Valladolid</city>
        <zip>47016</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Provincial de Zamora</name>
      <address>
        <city>Zamora</city>
        <zip>49021</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CI Cherkasy Regional Psychiatric Hospital of ChRC</name>
      <address>
        <city>Smila</city>
        <state>Cherkas'ka Oblast</state>
        <zip>20708</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Psychiatric Hospital</name>
      <address>
        <city>Kropyvnytskyi</city>
        <state>Kirovograd Region</state>
        <zip>25491</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kyiv City Psychoneurological Hospital #3 General Psychiatry Department No. 2</name>
      <address>
        <city>Kyiv</city>
        <state>Vasylkiv District Kyiv Region</state>
        <zip>08631</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;CIH Kharkiv Regional Clinical Psychiatric Hospital #3 Psychiatric Department of Primary Psychotic Episod Short Site name: CIH KRCPH #3 PD of PPE &quot;</name>
      <address>
        <city>Kharkiv</city>
        <zip>61068</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>SI Institute of Neurology,Psychiatry&amp;Narcology of NAMSU</name>
      <address>
        <city>Kharkiv</city>
        <zip>61068</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Institution &quot;Institute of Neurology, Psychiatry and Narcology of NAMS of Ukraine&quot;, Department of Urgent Psychiatry and Narcology</name>
      <address>
        <city>Kharkiv</city>
        <zip>61068</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kyiv Regional Medical Incorporation &quot;Psychiatry&quot;. Center of Novel Treatment and Rehabilitation of Psychotic disorders, build 5, Department #30</name>
      <address>
        <city>Kyiv</city>
        <zip>04080</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Kyiv CH on Railway Transport #2 of Branch Center of Healthcare Public Company Ukr Railway Short site name: Kyiv Railway Clinical Hospital № 2&quot;</name>
      <address>
        <city>Kyiv</city>
        <zip>3049</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CI Odesa Regional Medical Centre of Mental Health</name>
      <address>
        <city>Odesa</city>
        <zip>65014</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Bulgaria</country>
    <country>Croatia</country>
    <country>Czechia</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Lithuania</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Spain</country>
    <country>Ukraine</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2020</study_first_posted>
  <last_update_submitted>October 14, 2021</last_update_submitted>
  <last_update_submitted_qc>October 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pimavanserin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

